Clinical Outcomes of the CHIRP trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients with High-Risk Prostate Cancer.